Abstract

Second primary cancers after enrollment in the COMS trials for treatment of choroidal melanoma: COMS report no. 25 - Commentary

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call